Shares of biote Corp. (NASDAQ:BTMDW – Get Free Report) dropped 21.2% on Tuesday . The stock traded as low as $0.10 and last traded at $0.10. Approximately 9,085 shares traded hands during trading, a decline of 85% from the average daily volume of 58,814 shares. The stock had previously closed at $0.13.
biote Price Performance
The stock has a 50-day moving average of $0.59 and a 200-day moving average of $0.94.
biote Company Profile
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.
See Also
- Five stocks we like better than biote
- How to Evaluate a Stock Before BuyingÂ
- Garmin Navigates to New Highs Driven By Wearables Trend
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- Stock Analyst Ratings and Canadian Analyst Ratings
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.